相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CD34-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed, High-Risk Multiple Myeloma
Eric Smith et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Focus on Longitudinal Assessment of Donor Chimerism, Extramedullary Disease, and High-Risk Cytogenetic Features
Leo Rasche et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party
M. Sobh et al.
LEUKEMIA (2016)
Guidelines for determination of the number of prior lines of therapy in multiple myeloma
S. Vincent Rajkumar et al.
BLOOD (2015)
CD34+-Selected Stem Cell Boost without Further Conditioning for Poor Graft Function after Allogeneic Stem Cell Transplantation in Patients with Hematological Malignancies
Evgeny Klyuchnikov et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Impact of High-Risk Cytogenetics and Achievement of Molecular Remission on Long-Term Freedom from Disease after Autologous-Allogeneic Tandem Transplantation in Patients with Multiple Myeloma
Nicolaus Kroeger et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study
Gosta Gahrton et al.
BLOOD (2013)
Toxicity-reduced, myeloablative allograft followed by lenalidomide maintenance as salvage therapy for refractory/relapsed myeloma patients
N. Kroeger et al.
BONE MARROW TRANSPLANTATION (2013)
Pseudo-autologous hematopoietic SCT as treatment for a patient with multiple myeloma who relapsed following an allogeneic hematopoietic SCT
E. Palfreyman et al.
BONE MARROW TRANSPLANTATION (2013)
The occurrence of graft-versus-host disease is the major predictive factor for response to donor lymphocyte infusions in multiple myeloma
HM Lokhorst et al.
BLOOD (2004)
Donor lymphocyte infusion enhances remission status in patients with persistent disease after allografting for multiple myeloma
N Kröger et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
分享论文
